Case Studies in the Application of a Workflow-Based Crystallization Design for Optimized Impurity Rejection in Pharmaceutical Development-Reference-Cited by-同舟云学术

Case Studies in the Application of a Workflow-Based Crystallization Design for Optimized Impurity Rejection in Pharmaceutical Development

Published:2023-03-24 Issue:4 Volume:27 Page:610-626
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Agrawal Paridhi¹^ORCID,Rawal Saurin H.¹^ORCID,Reddy Venkata Ramana¹,Viswanath Shekhar K.¹,Merritt Jeremy M.¹^ORCID

Affiliation:

1. Synthetic Molecule Design and Development, Lilly Research Laboratories, Eli Lilly & Company, 1400 West Raymond Street, Indianapolis, Indiana 46221, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.2c00346

Reference41 articles.

1. Application of Process Analytical Technology-Based Feedback Control Strategies To Improve Purity and Size Distribution in Biopharmaceutical Crystallization

2. Recent Developments in the Crystallization Process: Toward the Pharmaceutical Industry

3. ICH Harmonised Tripartite Guideline Impurities in new drug substances Q3A (R2). Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; Citeseer: Geneva, Switzerland, 2006; Vol. 25.

4. ICH Harmonised Tripartite Guideline. current step. Impurities in New Drug Products, 2006; Vol. 4, pp 1–5.

5. Overview of Genotoxic Impurities in Pharmaceutical Development

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical Digital Design: From Chemical Structure through Crystal Polymorph to Conceptual Crystallization Process;Crystal Growth & Design;2024-06-24

2. Use of automation, dynamic image analysis, and process analytical technologies to enable data rich particle engineering efforts at the Drug Substance / Drug Product interface: A case study using Lovastatin;Chemical Engineering Research and Design;2024-05

3. Quality by design of solid‐phase peptide/protein coupling reaction via mechanistic reaction kinetics modeling approach;AIChE Journal;2024-04-12

4. Concomitant Precipitation of Solid-State Miscible Product-Impurity Phases in Solution Crystallization. Part 1: Theoretical Basis and Workflow for Efficient Impurity Rejection;Organic Process Research & Development;2024-01-26

5. Development of a Mechanistic Amino Acid Activation Reaction Kinetics Model for Safe and Efficient Solid Phase Peptide Synthesis;Industrial & Engineering Chemistry Research;2023-09-08